255 related articles for article (PubMed ID: 29160447)
21. Main characteristics of patients of primary health care services in Brazil.
Guibu IA; Moraes JC; Guerra AA; Costa EA; Acurcio FA; Costa KS; Karnikowski MGO; Soeiro OM; Leite SN; Álvares J
Rev Saude Publica; 2017 Nov; 51(suppl 2):17s. PubMed ID: 29160451
[TBL] [Abstract][Full Text] [Related]
22. Infrastructure of pharmacies of the primary health care in the Brazilian Unified Health System: Analysis of PNAUM - Services data.
Leite SN; Manzini F; Álvares J; Guerra AA; Costa EA; Acurcio FA; Guibu IA; Costa KS; Karnikowski MGO; Soeiro OM; Farias MR
Rev Saude Publica; 2017 Nov; 51(suppl 2):13s. PubMed ID: 29160456
[TBL] [Abstract][Full Text] [Related]
23. Resource allocation for pharmaceutical procurement in the Brazilian Unified Health System.
Vieira FS; Zucchi P
Rev Saude Publica; 2011 Oct; 45(5):906-13. PubMed ID: 21808832
[TBL] [Abstract][Full Text] [Related]
24. Pharmaceutical services in Rio de Janeiro Municipality, Brazil: development regarding selected aspects from 2008 to 2014.
Silva RM; Pereira NC; Mendes LV; Luiza VL
Cien Saude Colet; 2016 May; 21(5):1421-32. PubMed ID: 27166892
[TBL] [Abstract][Full Text] [Related]
25. [Pharmaceutical assistance in the basic units of health: from the national drug policy to the basic attention to health].
de Oliveira LC; Assis MM; Barboni AR
Cien Saude Colet; 2010 Nov; 15 Suppl 3():3561-7. PubMed ID: 21120344
[TBL] [Abstract][Full Text] [Related]
26. [Assessment of the municipal administration in the promotion of rational use of medicines in medium and large cities in Santa Catarina, Brazil].
Monteiro ER; Lacerda JT; Natal S
Cad Saude Publica; 2021; 37(5):e00112920. PubMed ID: 34133637
[TBL] [Abstract][Full Text] [Related]
27. [Sources of medicines for chronic patients using the Brazilian Unified National Health System].
Matta SR; Bertoldi AD; Emmerick ICM; Fontanella AT; Costa KS; Luiza VL;
Cad Saude Publica; 2018 Mar; 34(3):e00073817. PubMed ID: 29590242
[TBL] [Abstract][Full Text] [Related]
28. Does socioeconomic inequality occur in the multimorbidity among Brazilian adults?
Costa ÂK; Bertoldi AD; Fontanella AT; Ramos LR; Arrais PSD; Luiza VL; Mengue SS; Nunes BP
Rev Saude Publica; 2020; 54():138. PubMed ID: 33331530
[TBL] [Abstract][Full Text] [Related]
29. Access to medicines in Brazil based on monetary and non-monetary acquisition data obtained from the 2008/2009 Household Budget Survey.
Goes FC; Homem-de-Mello M; Caldas ED
Rev Saude Publica; 2016 Dec; 50():79. PubMed ID: 28099666
[TBL] [Abstract][Full Text] [Related]
30. [Access to medicines in the public sector: analysis of users of the Brazilian Unified National Health System].
Boing AC; Bertoldi AD; Boing AF; Bastos JL; Peres KG
Cad Saude Publica; 2013 Apr; 29(4):691-701. PubMed ID: 23568299
[TBL] [Abstract][Full Text] [Related]
31. [Access to high-cost drugs in Brazil from the perspective of physicians, pharmacists and patients].
Rover MR; Vargas-Pelaez CM; Rocha Farias M; Nair Leite S
Gac Sanit; 2016; 30(2):110-6. PubMed ID: 26850831
[TBL] [Abstract][Full Text] [Related]
32. Infrastructure evaluation of Pharmaceutical Services in the National Health System of Minas Gerais.
Barbosa MM; Garcia MM; Nascimento RCRMD; Reis EA; Guerra AA; Acurcio FA; Álvares J
Cien Saude Colet; 2017 Aug; 22(8):2475-2486. PubMed ID: 28793065
[TBL] [Abstract][Full Text] [Related]
33. Comments on "The organization of pharmaceutical services by 'health region' in Brazil's Unified Health System".
Araújo SQ; Costa KS; Luiza VL; Lavras C; Santana EA; Tavares NUL
Cien Saude Colet; 2017 Apr; 22(4):1181-1191. PubMed ID: 28444044
[TBL] [Abstract][Full Text] [Related]
34. [Horus: technological innovation in pharmaceutical assistance within the Brazilian unified health system].
Costa KS; Nascimento JM
Rev Saude Publica; 2012 Dec; 46 Suppl 1():91-9. PubMed ID: 23250393
[TBL] [Abstract][Full Text] [Related]
35. [Determinants of equity in financing medicines in Argentina: an empirical study].
Dondo M; Monsalvo M; Garibaldi LA
Cad Saude Publica; 2016 Jan; 32(1):. PubMed ID: 26886366
[TBL] [Abstract][Full Text] [Related]
36. Health financing in Brazil and the goals of the 2030 Agenda: high risk of failure.
Vieira FS
Rev Saude Publica; 2020; 54():127. PubMed ID: 33331523
[TBL] [Abstract][Full Text] [Related]
37. Influence of pharmaceutical services organization on the availability of essential medicines in a public health system.
Rocha WH; Teodoro JÁ; Assis Acurcio F; Guerra AA; Gomes Moura IC; Godman B; Kurdi A; Rezende Macedo do Nascimento RC; Almeida AM
J Comp Eff Res; 2021 Apr; 10(6):519-532. PubMed ID: 33739138
[No Abstract] [Full Text] [Related]
38. Socioeconomic inequalities in expenditures and income committed to the purchase of medicines in Southern Brazil.
Boing AC; Bertoldi AD; Peres KG
Rev Saude Publica; 2011 Oct; 45(5):897-905. PubMed ID: 21829974
[TBL] [Abstract][Full Text] [Related]
39. Access to high-priced medicines: inequalities in the organization and the results among Brazilian states.
Rover MRM; Faraco EB; Vargas-Peláez CM; Colussi CF; Storpirtis S; Farias MR; Leite SN
Cien Saude Colet; 2021 Nov; 26(11):5499-5508. PubMed ID: 34852085
[TBL] [Abstract][Full Text] [Related]
40. National Survey on Access, Use and Promotion of Rational Use of Medicines (PNAUM): evaluation of pharmaceutical services in the primary health care.
Akerman M; Freitas O
Rev Saude Publica; 2017 Nov; 51(suppl 2):1s. PubMed ID: 29160468
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
